Send to

Choose Destination
See comment in PubMed Commons below
J Am Coll Cardiol. 2013 Aug 20;62(8):677-84. doi: 10.1016/j.jacc.2013.01.080. Epub 2013 Mar 21.

Cardiometabolic consequences of gestational dysglycemia.

Author information

Mount Sinai Hospital Department of Medicine, University of Toronto, Ontario, Canada.


The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease. A careful and systematic dissection of the hormonal, metabolic, and vascular changes occurring in such women during pregnancy and over the postpartum years provides a unique opportunity to identify conventional and novel conditions and biomarkers whose modification may attenuate adverse long-term outcomes, particularly cardiovascular risk. The purpose of this review is to summarize current understanding of the magnitude of such risk and its potential causes, with a particular focus on postpartum alterations in endothelial and vascular smooth muscle responsiveness.


AUC(gluc); BMI; CI; CVD; EDD; EID; FMD; GCT; GDM; GIGT; HR; NGT; NO; OGTT; OR; T2DM; area under the glucose curve; body mass index; cardiovascular disease; cardiovascular risk; confidence interval; endothelial function; endothelium-dependent dilation; endothelium-independent dilation; flow-mediated dilation; gestational diabetes; gestational diabetes mellitus; gestational impaired glucose tolerance; glucose challenge test; hazard ratio; nitric oxide; normal glucose tolerance; odds ratio; oral glucose tolerance test; type 2 diabetes mellitus

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center